1. Home
  2. SM vs ALGN Comparison

SM vs ALGN Comparison

Compare SM & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SM Energy Company

SM

SM Energy Company

N/A

Current Price

$28.57

Market Cap

9.1B

Sector

Energy

ML Signal

N/A

Logo Align Technology Inc.

ALGN

Align Technology Inc.

N/A

Current Price

$155.22

Market Cap

10.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SM
ALGN
Founded
1908
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Industrial Specialties
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
10.5B
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
SM
ALGN
Price
$28.57
$155.22
Analyst Decision
Buy
Buy
Analyst Count
18
16
Target Price
$44.33
★ $185.79
AVG Volume (30 Days)
★ 3.2M
1.1M
Earning Date
11-03-2026
10-28-2026
Dividend Yield
★ 3.00%
N/A
EPS Growth
N/A
★ 0.53
EPS
3.66
★ 4.98
Revenue
★ $3,154,000,000.00
$387,126,000.00
Revenue This Year
$158.35
$2.24
Revenue Next Year
$1.33
$2.86
P/E Ratio
★ $8.01
$32.06
Revenue Growth
17.24
★ 23.95
52 Week Low
$17.45
$138.05
52 Week High
$41.56
$200.44

Technical Indicators

Market Signals
Indicator
SM
ALGN
Relative Strength Index (RSI) 33.86 45.37
Support Level $26.73 $149.55
Resistance Level $33.40 $181.05
Average True Range (ATR) 1.70 6.30
MACD -0.39 -1.19
Stochastic Oscillator 9.29 17.37

Price Performance

Historical Comparison
SM
ALGN

About SM SM Energy Company

SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: